| Ab04105-23.0-BT
| Anti-Viral hemorrhagic septicemia virus [3F1H10]
| 1 mg
| Absolute Antibody
| IF; Immunoblot; ELISA; PNT; in vitro; in vivo
|
|
| Viral hemorrhagic septicemia virus; VHSV
| Request Quotation
| Request
|
| Ab04144-23.0
| Anti-hepsin [Mab53]
| 100 ug
| Absolute Antibody
| ELISA
|
|
| Human
| Request Quotation
| Request
|
| Ab04108-15.0
| Anti-GP38 [CC5-17]
| 50 ug
| Absolute Antibody
| ELISA; SPR; BLI
|
|
| Crimean-Congo Hemorrhagic Fever Virus; CCHFV
| Request Quotation
| Request
|
| Ab04163-23.0-BT
| Anti-RANK-L [WBP114_7.80]
| 1 mg
| Absolute Antibody
| ELISA; SPR; inhibition
|
|
| Human
| Request Quotation
| Request
|
| Ab04197-23.0-BT
| Anti-gelatinase B [REGA-3G12]
| 1 mg
| Absolute Antibody
| ELISA; Immunoblot; Inhibition; IP; WB
|
|
| Human
| Request Quotation
| Request
|
| Ab04168-23.0
| Anti-Capsular antigen [P2I67]
| 100 ug
| Absolute Antibody
| ELISA
|
|
| Other
| Request Quotation
| Request
|
| Ab04131-23.0-BT
| Anti-Envelope glycoprotein H and L [rec-RC-IgG]
| 1 mg
| Absolute Antibody
| IHC; IP; neutralize
|
|
| Varicella zoster virus (VZV)
| Request Quotation
| Request
|
| Ab04115-23.0-BT
| Anti-VWFpp [JG7]
| 1 mg
| Absolute Antibody
| ELISA
|
|
| Human
| Request Quotation
| Request
|
| Ab04181-3.0-BT
| Anti-Integrin alpha-4/beta-7 [Vedolizumab (LDP-02)]
| 1 mg
| Absolute Antibody
| FC; therapeutic
|
|
| Human
| Request Quotation
| Request
|
| Ab04113-1.1-BT
| Anti-OPG [AbAb01OPG]
| 1 mg
| Absolute Antibody
| ELISA
|
|
| Human
| Request Quotation
| Request
|
| Ab04181-23.0-BT
| Anti-Integrin alpha-4/beta-7 [Vedolizumab (LDP-02)]
| 1 mg
| Absolute Antibody
| FC; therapeutic
|
|
| Human
| Request Quotation
| Request
|
| Ab04154-1.1
| Anti-HB-EGF [KM3566]
| 100 ug
| Absolute Antibody
| ELISA; WB; inhibition; neutralization; FC
|
|
| Human
| Request Quotation
| Request
|
| Ab04160-23.0-BT
| Anti-CD5 [5D7]
| 1 mg
| Absolute Antibody
| FC; functional assay
|
|
| Human; cynomolgus monkey
| Request Quotation
| Request
|
| Ab04170-23.0
| Anti-LgR5 [1-12]
| 100 ug
| Absolute Antibody
| ELISA; FACS; IHC
|
|
| Human
| Request Quotation
| Request
|
| Ab04153-23.0
| Anti-Chikungunya virus [CAP5A-F6]
| 100 ug
| Absolute Antibody
| FC; SPR; neutralizing; PRNT
|
|
| Chikungunya virus
| Request Quotation
| Request
|
| Ab04184-3.0
| Anti-FAP alpha [BIBH1 (Sibrotuzumab, huF19)]
| 100 ug
| Absolute Antibody
| FC; IHC; ELISA
|
|
| Human
| Request Quotation
| Request
|
| Ab04174-23.0-BT
| Anti-REG1A [A6]
| 1 mg
| Absolute Antibody
| WB; ELISA
|
|
| Human
| Request Quotation
| Request
|
| Ab04130-1.1
| Anti-Envelope glycoprotein H and L [94]
| 100 ug
| Absolute Antibody
| ELISA; neutralize; IP
|
|
| Varicella zoster virus (VZV); human herpesvirus 3
| Request Quotation
| Request
|
| Ab04153-23.0-BT
| Anti-Chikungunya virus [CAP5A-F6]
| 1 mg
| Absolute Antibody
| FC; SPR; neutralizing; PRNT
|
|
| Chikungunya virus
| Request Quotation
| Request
|
| Ab04117-1.1
| Anti-HCV core protein [19D9D6]
| 100 ug
| Absolute Antibody
| ELISA
|
|
| Hepatitis C virus; HCV
| Request Quotation
| Request
|
| Ab04160-1.1
| Anti-CD5 [5D7]
| 100 ug
| Absolute Antibody
| FC; functional assay
|
|
| Human; cynomolgus monkey
| Request Quotation
| Request
|
| Ab04161-2.0-BT
| Anti-RANK-L [2A4]
| 1 mg
| Absolute Antibody
| ELISA
|
|
| Human
| Request Quotation
| Request
|
| Ab04137-10.0-BT
| Anti-CD44 [064-003]
| 1 mg
| Absolute Antibody
| ADCC
|
|
| Human
| Request Quotation
| Request
|
| Ab04154-23.0-BT
| Anti-HB-EGF [KM3566]
| 1 mg
| Absolute Antibody
| ELISA; WB; inhibition; neutralization; FC
|
|
| Human
| Request Quotation
| Request
|
| Ab04111-23.0
| Anti-OPGL [9H7]
| 100 ug
| Absolute Antibody
| ELISA; SPR; NTRL; in vivo
|
|
| Human; Cynomolgus Monkey
| Request Quotation
| Request
|
| Ab04158-23.0-BT
| Anti-3-SLeX [E2-B4]
| 1 mg
| Absolute Antibody
| IHC; IB; ELISA
|
|
| Human
| Request Quotation
| Request
|
| Ab04174-1.1-BT
| Anti-REG1A [A6]
| 1 mg
| Absolute Antibody
| WB; ELISA
|
|
| Human
| Request Quotation
| Request
|
| Ab04173-10.0-BT
| Anti-FLNB [SH7]
| 1 mg
| Absolute Antibody
| ELISA; BLI
|
|
| Human
| Request Quotation
| Request
|
| Ab04101-10.0
| Anti-PLC-gamma phosphorylated [AbAb1-PLCy]
| 100 ug
| Absolute Antibody
| ELISA; WB; IP
|
|
| Human; mouse
| Request Quotation
| Request
|
| Ab04157-1.1
| Anti-SSEA4 [E2-F8 ]
| 100 ug
| Absolute Antibody
| IHC; IB; ELISA
|
|
| Human
| Request Quotation
| Request
|
| Ab04181-10.0
| Anti-Integrin alpha-4/beta-7 [Vedolizumab (LDP-02)]
| 100 ug
| Absolute Antibody
| FC; therapeutic
|
|
| Human
| Request Quotation
| Request
|
| Ab04132-23.0
| Anti-Envelop glycoprotein B [93k]
| 100 ug
| Absolute Antibody
| WB; IP; neutralize
|
|
| Varicella zoster virus (VZV); human herpesvirus 3
| Request Quotation
| Request
|
| Ab04153-10.0-BT
| Anti-Chikungunya virus [CAP5A-F6]
| 1 mg
| Absolute Antibody
| FC; SPR; neutralizing; PRNT
|
|
| Chikungunya virus
| Request Quotation
| Request
|
| Ab04108-15.0-BT
| Anti-GP38 [CC5-17]
| 500 ug
| Absolute Antibody
| ELISA; SPR; BLI
|
|
| Crimean-Congo Hemorrhagic Fever Virus; CCHFV
| Request Quotation
| Request
|
| Ab04117-23.0
| Anti-HCV core protein [19D9D6]
| 100 ug
| Absolute Antibody
| ELISA
|
|
| Hepatitis C virus; HCV
| Request Quotation
| Request
|
| Ab04144-23.0-BT
| Anti-hepsin [Mab53]
| 1 mg
| Absolute Antibody
| ELISA
|
|
| Human
| Request Quotation
| Request
|
| Ab04198-23.0
| Anti-RSPO1 [89M5]
| 100 ug
| Absolute Antibody
| SPR; FACS; in vivo
|
|
| Human; Mouse
| Request Quotation
| Request
|
| Ab04130-10.0-BT
| Anti-Envelope glycoprotein H and L [94]
| 1 mg
| Absolute Antibody
| ELISA; neutralize; IP
|
|
| Varicella zoster virus (VZV); human herpesvirus 3
| Request Quotation
| Request
|
| Ab04138-2.0
| Anti-RANK-L [14F3]
| 100 ug
| Absolute Antibody
| ELISA; Inhibition
|
|
| Human
| Request Quotation
| Request
|
| Ab04107-15.0-BT
| Anti-IgG [RF61]
| 500 ug
| Absolute Antibody
| ELISA; HA
|
|
| Human
| Request Quotation
| Request
|
| Ab04145-23.0
| Anti-domoic acid [2H12]
| 100 ug
| Absolute Antibody
| ELISA
|
|
| Other
| Request Quotation
| Request
|
| Ab04162-1.1-BT
| Anti-RANK-L [WBP114_5.20]
| 1 mg
| Absolute Antibody
| ELISA; SPR; inhibition
|
|
| Human
| Request Quotation
| Request
|
| Ab04187-10.0-BT
| Anti-CCL11 [CAT-213 (Bertilimumab; iCo-008)]
| 1 mg
| Absolute Antibody
| ELISA; inhibit; neutralize
|
|
| Human
| Request Quotation
| Request
|
| Ab04103-10.0
| Anti-Tp47 membrane protein [ZJTP47-1B3]
| 100 ug
| Absolute Antibody
| WB; ELISA
|
|
| Other
| Request Quotation
| Request
|
| Ab04164-23.0
| Anti-glycoprotein [7C8F1]
| 100 ug
| Absolute Antibody
| ELISA
|
|
| panfilovirus
| Request Quotation
| Request
|
| Ab04165-23.0
| Anti-panfilovirus glycoprotein [4B3B5]
| 100 ug
| Absolute Antibody
| ELISA
|
|
| panfilovirus
| Request Quotation
| Request
|
| Ab04164-10.0
| Anti-glycoprotein [7C8F1]
| 100 ug
| Absolute Antibody
| ELISA
|
|
| panfilovirus
| Request Quotation
| Request
|
| Ab04165-10.0-BT
| Anti-panfilovirus glycoprotein [4B3B5]
| 1 mg
| Absolute Antibody
| ELISA
|
|
| panfilovirus
| Request Quotation
| Request
|
| Ab04131-23.0
| Anti-Envelope glycoprotein H and L [rec-RC-IgG]
| 100 ug
| Absolute Antibody
| IHC; IP; neutralize
|
|
| Varicella zoster virus (VZV)
| Request Quotation
| Request
|
| Ab04106-21.0-BT
| Anti-Viral hemorrhagic septicemia virus [3F1A2 ]
| 500 ug
| Absolute Antibody
| ELISA; PNT; in vitro
|
|
| Viral hemorrhagic septicemia virus; VHSV
| Request Quotation
| Request
|